Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Acpt protein, rat

Known as: histidine acid phosphatase, rat, ACPT phosphatase, rat, testicular acid phosphatase, rat 
National Institutes of Health

Related topics

Related topics

2 relations
ACPT gene

Broader (1)

Acid Phosphatase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity
Activation of group III metabotropic glutamate (mGlu) receptors has been recently highlighted as a potential approach in the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2009
2009
The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems
Our earlier studies have demonstrated that (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid ACPT-I, a group III mGlu… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Highly Cited
2008
Highly Cited
2008
Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain
&NA; Glutamate plays a key role in modulation of nociceptive processing. This excitatory amino acid exerts its action through two… Expand
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 6
2008
2008
Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents
Several lines of evidence implicate dysfunction of glutamatergic neurotransmission in the pathophysiology of schizophrenia… Expand
2008
2008
Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats
Non-dopaminergic drugs acting either on adenosine A2A or metabotropic glutamate (mGlu) receptors reduce motor impairment in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
2007
Highly Cited
2007
Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease.
Drugs activating group III metabotropic glutamate receptors (mGluRs) represent therapeutic alternatives to L-DOPA (L-3,4… Expand
Highly Cited
2006
Highly Cited
2006
Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats
Summary.Numerous pharmacological data indicate involvement of glutamate, the major excitatory neurotransmitter in the brain, in… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
2006
2006
Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling.
Recent literature data and the results of our earlier pharmacological studies, have provided evidence that antagonists of group I… Expand
  • figure 1
  • figure 4
  • figure 2
  • figure 3
Highly Cited
2004
Highly Cited
2004
Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats
It was well established that compounds which decrease glutamatergic transmission via blockade of NMDA or group I mGlu receptors… Expand
Highly Cited
2002
Highly Cited
2002
Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.
We examined the anxiolytic-like activity of (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) using the Vogel… Expand
  • table 2
  • table 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE